- Home
- UNCY vs VTSI Comparison
UNCY vs VTSI Comparison
Compare UNCY & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- VTSI
- Stock Information
- Founded
- UNCY 2016
- VTSI 1993
- Country
- UNCY United States
- VTSI United States
- Employees
- UNCY N/A
- VTSI N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- VTSI Miscellaneous manufacturing industries
- Sector
- UNCY Health Care
- VTSI Consumer Discretionary
- Exchange
- UNCY Nasdaq
- VTSI Nasdaq
- Market Cap
- UNCY 74.2M
- VTSI 61.9M
- IPO Year
- UNCY 2021
- VTSI N/A
- Fundamental
- Price
- UNCY $4.93
- VTSI $5.72
- Analyst Decision
- UNCY Strong Buy
- VTSI Strong Buy
- Analyst Count
- UNCY 5
- VTSI 1
- Target Price
- UNCY $55.20
- VTSI $7.00
- AVG Volume (30 Days)
- UNCY 419.1K
- VTSI 55.0K
- Earning Date
- UNCY 11-12-2025
- VTSI 11-11-2025
- Dividend Yield
- UNCY N/A
- VTSI N/A
- EPS Growth
- UNCY N/A
- VTSI N/A
- EPS
- UNCY N/A
- VTSI 0.10
- Revenue
- UNCY N/A
- VTSI $27,068,543.00
- Revenue This Year
- UNCY N/A
- VTSI $10.31
- Revenue Next Year
- UNCY $19,912.34
- VTSI $12.71
- P/E Ratio
- UNCY N/A
- VTSI $57.65
- Revenue Growth
- UNCY N/A
- VTSI N/A
- 52 Week Low
- UNCY $3.71
- VTSI $3.57
- 52 Week High
- UNCY $11.00
- VTSI $8.53
- Technical
- Relative Strength Index (RSI)
- UNCY 66.90
- VTSI 48.29
- Support Level
- UNCY $4.33
- VTSI $5.76
- Resistance Level
- UNCY $4.81
- VTSI $6.19
- Average True Range (ATR)
- UNCY 0.31
- VTSI 0.31
- MACD
- UNCY 0.04
- VTSI 0.04
- Stochastic Oscillator
- UNCY 70.07
- VTSI 50.00
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.